NCT06424262 - Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions

Hearing Loss, Bilateral SensorineuralHearing Loss, SensorineuralHearing Loss, BilateralHearing Loss, Cochlear

Interventions

DEVICE

CI622D

A dexamethasone-eluting Slim Straight electrode

DEVICE

CI622

A standard Slim Straight electrode

Trial Locations (13)

Macquarie University, Sydney

Royal Prince Alfred Hospital, Sydney

Westmead Hospital, Sydney

Westmead Private Hospital, Sydney

St Vincent Private Hospital, Melbourne

Royal Victorian Eye and Ear Hospital, Melbourne E.

Centre Hospitalier Universitaire de Lille, Lille

Hôpital Universitaire Pitié-Salpêtrière, Paris

Centre Hospitalier Universitaire Toulouse, Toulouse

Universitätsklinikum Freiburg, Freiburg im Breisgau

Medizinische Hochschule Hannover, Hanover

Manchester Royal Infirmary, Manchester

University of Southampton, Southampton